Cargando…
A case of markedly impaired wound repair with angiostatic pazopanib in a patient who had Mohs surgery for a basal cell carcinoma
This case report highlights the adverse effects of pazopanib, a vascular endothelial growth factor receptor inhibitor, on wound healing after Mohs surgery. A 79-year-old male with metastatic renal cell carcinoma of the lung, on 600 mg daily pazopanib, underwent Mohs surgery for a nodular basal cell...
Autores principales: | Nahm, William J, de Imus, Gail, Mathe, Christopher A, Saap, Liliana, Joseph, Saiyan, Chen, Stanley, Falanga, Vincent |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10510339/ https://www.ncbi.nlm.nih.gov/pubmed/37736143 http://dx.doi.org/10.1177/2050313X231200967 |
Ejemplares similares
-
Mohs Surgery for Periocular Basal Cell Carcinoma Without a Mohs Surgeon: The First Series in Hong Kong
por: Chan, Regine, et al.
Publicado: (2023) -
Oncofoetal insulin receptor isoform A marks the tumour endothelium; an underestimated pathway during tumour angiogenesis and angiostatic treatment
por: Nowak-Sliwinska, Patrycja, et al.
Publicado: (2018) -
Angiostatic vaccines, an underestimated approach of cancer therapy
por: Griffioen, Arjan W.
Publicado: (2014) -
NF-κB: a new player in angiostatic therapy
por: Tabruyn, Sebastien P., et al.
Publicado: (2008) -
Angiostatic kinase inhibitors to sustain photodynamic angio-occlusion
por: Nowak-Sliwinska, Patrycja, et al.
Publicado: (2012)